Dewpoint Therapeutics

OverviewSuggest Edit

Dewpoint Therapeutics is a company focused on condensate biology. It uses biomolecular condensates to develop drugs for neurodegeneration, cancer, inflammation, infectious diseases, metabolic diseases, and rare genetic disorders.

TypePrivate
Founded2018
HQBoston, MA, US
Websitedewpointx.com

Latest Updates

Employees (est.) (Sept 2021)105(+5%)
Cybersecurity ratingBMore

Key People/Management at Dewpoint Therapeutics

Richard Young

Richard Young

Scientific Founder
Violeta Yu

Violeta Yu

Director, Discovery Biology
Joel Sendek

Joel Sendek

Chief Financial Officer
Show more

Dewpoint Therapeutics Office Locations

Dewpoint Therapeutics has offices in Boston, Sacramento and Dresden
Boston, MA, US (HQ)
6 Tide St #300
Sacramento, CA, US
1625 N Market Blvd suite n 112
Dresden, DE
Tatzberg 47
Show all (3)

Dewpoint Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2018

Dewpoint Therapeutics total Funding

$137 m

Dewpoint Therapeutics latest funding size

$77 m

Time since last funding

a year ago

Dewpoint Therapeutics investors

Dewpoint Therapeutics's latest funding round in September 2020 was reported to be $77 m. In total, Dewpoint Therapeutics has raised $137 m
Show all financial metrics

Dewpoint Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Dewpoint Therapeutics Online and Social Media Presence

Embed Graph

Dewpoint Therapeutics News and Updates

Dewpoint Therapeutics Appoints Isaac Klein, M.D., Ph.D., as Chief Scientific Officer

BOSTON, April 21, 2021 /PRNewswire/ -- Dewpoint Therapeutics, the biomolecular condensates company, today announced the appointment of Isaac Klein, M.D., Ph.D., as Chief Scientific Officer, effective May 3, 2021. Dr. Klein is a physician-scientist and medical oncologist at the Dana-Farber...

Dewpoint Therapeutics Appoints Ameet Nathwani as Chief Executive Officer

BOSTON, Oct. 13, 2020 /PRNewswire/ -- Dewpoint Therapeutics, the biomolecular condensates company, today announced it has appointed Ameet Nathwani, M.D., as Chief Executive Officer and member of the Board of Directors. "We are extremely fortunate to have found someone who embodies our...

Dewpoint Therapeutics Blogs

Dewpoint scientific founder Tony Hyman elected to the Leopoldina National Academy of Sciences

Professor Anthony Hyman is a new member of the Leopoldina Dresden cell biologist elected to the Leopoldina National Academy of Sciences Prof. Dr. Anthony Hyman © Sven Döring The German National Academy of Sciences Leopoldina has elected the Dresden cell biologist Prof. Dr. Anthony Hyman as one of it…

Volastra Therapeutics and Dewpoint Therapeutics Partner to Discover Novel Condensate Modulators for Cancer Treatment

The post Volastra Therapeutics and Dewpoint Therapeutics Partner to Discover Novel Condensate Modulators for Cancer Treatment appeared first on Dewpoint.

Dewpoint Therapeutics Appoints Regina Barzilay, Ph.D., to its Board of Directors

The post Dewpoint Therapeutics Appoints Regina Barzilay, Ph.D., to its Board of Directors appeared first on Dewpoint.

Dewpoint Therapeutics Appoints Joel Sendek as Chief Financial Officer

The post Dewpoint Therapeutics Appoints Joel Sendek as Chief Financial Officer appeared first on Dewpoint.

Drug startups coalesce around condensates

Once a neglected biological phenomenon, condensates are attracting interest from small companies and large pharmas. Three startups debuted in late 2020, all aiming to treat disease by manipulating the physiochemical and regulatory processes in cells that drive membraneless hubs associated with disea…

Dewpoint Appoints Kara Carter, Ph.D., Senior Vice President of Discovery Biology

The post Dewpoint Appoints Kara Carter, Ph.D., Senior Vice President of Discovery Biology appeared first on Dewpoint.
Show more

Dewpoint Therapeutics Frequently Asked Questions

  • When was Dewpoint Therapeutics founded?

    Dewpoint Therapeutics was founded in 2018.

  • Who are Dewpoint Therapeutics key executives?

    Dewpoint Therapeutics's key executives are Richard Young, Violeta Yu and Joel Sendek.

  • How many employees does Dewpoint Therapeutics have?

    Dewpoint Therapeutics has 105 employees.

  • Who are Dewpoint Therapeutics competitors?

    Competitors of Dewpoint Therapeutics include Strand Therapeutics, ReViral and Sosei Heptares.

  • Where is Dewpoint Therapeutics headquarters?

    Dewpoint Therapeutics headquarters is located at 6 Tide St #300, Boston.

  • Where are Dewpoint Therapeutics offices?

    Dewpoint Therapeutics has offices in Boston, Sacramento and Dresden.

  • How many offices does Dewpoint Therapeutics have?

    Dewpoint Therapeutics has 3 offices.